Microbial resistance: lessons from the EPIC study

被引:53
作者
Vincent, JL [1 ]
机构
[1] Free Univ Brussels, Erasme Univ Hosp, Dept Intens Care, B-1070 Brussels, Belgium
关键词
D O I
10.1007/s001340051111
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
In 1992, a one day point prevalence study (EPIC) was conducted in European intensive care units (ICUs) to determine the prevalence of nosocomial infection among ICU patients. Of the 10,038 patients included, 45 % were infected and 21 % had a nosocomial ICU-acquired infection. Many of the organisms responsible for these infections were resistant to commonly used antibiotics. For example, 60 % of the Staphylococcus aureus isolated were resistant to methicillin and 46 % of Pseudomonas aeruginosa were resistant to gentamicin. The incidence of nosocomial infection varied between countries as did the incidence of antibiotic resistance. Mortality rates were higher in countries with higher rates of nosocomial infection and higher again in those countries with higher rates of resistant organisms. Antibiotic resistance is rising and clearly efforts to contain its development and spread are vital. Basic infection control procedures such as hand-washing must be developed and implemented, and antibiotic prescribing needs to be rationalized. The international variations in resistance rates, even within Europe, highlight the importance of being familiar with local resistance patterns when prescribing. The assistance of an infectious diseases specialist can be invaluable in providing a global overview of the local microbial milieu and of antibiotic resistance patterns. Epidemiological studies of this sort can provide useful information which can be used to stimulate debate on the reasons behind regional differences in infection and help in the development of strategies to combat the rising tide of microbial antibiotic resistance.
引用
收藏
页码:S3 / S8
页数:6
相关论文
共 35 条
[11]   Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries [J].
Hanberger, H ;
Garcia-Rodriguez, JA ;
Gobernado, M ;
Goossens, H ;
Nilsson, LE ;
Struelens, MJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (01) :67-71
[12]  
Hiramatsu Keiichi, 1998, American Journal of Medicine, V104, p7S, DOI 10.1016/S0002-9343(98)00149-1
[13]  
Ibelings MMS, 1998, EUR J SURG, V164, P411
[14]   Antibiotic susceptibility in aerobic gram-negative bacilli isolated in intensive care units in 39 French teaching hospitals (ICU study) [J].
Jarlier, V ;
Fosse, T ;
Philippon, A .
INTENSIVE CARE MEDICINE, 1996, 22 (10) :1057-1065
[15]   NOSOCOMIAL INFECTION-RATES IN ADULT AND PEDIATRIC INTENSIVE-CARE UNITS IN THE UNITED-STATES [J].
JARVIS, WR ;
EDWARDS, JR ;
CULVER, DH ;
HUGHES, JM ;
HORAN, T ;
EMORI, TG ;
BANERJEE, S ;
TOLSON, J ;
HENDERSON, T ;
GAYNES, RP ;
MARTONE, WJ .
AMERICAN JOURNAL OF MEDICINE, 1991, 91 :S185-S191
[16]   Bacterial resistance to antimicrobial agents: An overview from Korea [J].
Kim, WJ ;
Park, SC .
YONSEI MEDICAL JOURNAL, 1998, 39 (06) :488-494
[17]   Scheduled change of antibiotic classes - A strategy to decrease the incidence of ventilator-associated pneumonia [J].
Kollef, MH ;
Vlasnik, J ;
Sharpless, L ;
Pasque, C ;
Murphy, D ;
Fraser, V .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (04) :1040-1048
[18]   Current concepts - The prevention of ventilator-associated pneumonia [J].
Kollef, MH .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (08) :627-634
[19]   Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: A case controlled study [J].
Krcmery, V ;
Spanik, S ;
Krupova, I ;
Trupl, J ;
Kunova, A ;
Smid, M ;
Pichnova, E .
JOURNAL OF CHEMOTHERAPY, 1998, 10 (04) :320-325
[20]   Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E-faecium [J].
Linden, PK ;
Pasculle, AW ;
Manez, R ;
Kramer, DJ ;
Fung, JJ ;
Pinna, AD ;
Kusne, S .
CLINICAL INFECTIOUS DISEASES, 1996, 22 (04) :663-670